Skip to content

AMBAX

Active Private limited companyfounded 2021active for 5 yearsMolenstraat 73, 9820 Merelbeke-MelleKBO/BCE: BE 0771.351.522

Lifetime

4 annual accounts with figures on one time axis
peak of €148,826 in 2025
€148,826▲ 41.1%
peak of €76,915 in 2025
€76,915▲ 102%
peak of €232,666 in 2025
€232,666▲ 48.6%
€88,537▲ 199%
Board1 name since 2021
1 director
Documentsfilings and deeds
23-07-20268 days before the deadline
2025micro format
Gross margin from €105,443 to €148,826Result from €38,108 to €76,915Registered-office move 25-11Dividend €833Equity from €156,585 to €232,666Debts from €29,631 to €88,537

Key points

from the 2025 annual accounts

Equity

€232,666 ▲ 48.6%
€157,0002024€233,0002025

Equity rose in 2025 from €156,585 to €232,666.

Turnover

≈ €280,000 estimated

The micro format states no turnover.

Debts

€88,537 ▲ 199%
Suppliers
+28,901
Other debts
+18,139
The rest
+11,865

Debts rose by €58,905 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Liquidity

4.14 was 7.94 in 2024

Short-term debts rose from €29,143 to €88,032.

Filings

4 annual accounts since 2022
AprilJune31 JulyOctober2022202320242025

The last four annual accounts were filed 8 to 34 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as AMBAX has now. Each dot stands for 68 companies, two years later.

94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for AMBAX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 07-07-2021
  • 300 sharesdeed of 15-07-2021
Board & ownership

Recent changes

Registered-office move General meeting of 07-11-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0771351522
Incorporation Founding capital of €3,000 · Founded by · appointed as director · published on 15-07-2021 · Gazette deed
First establishment Molenstraat 73, Merelbeke-Melle
All 12 events

Comparable companies

same main activity, similar in size and age
Company
AMBAX Merelbeke-Melle €365,244 €148,826 63.7% -
Dr. Anaïs Depicker - Reumatologie Merelbeke-Melle €378,791 €159,411 5.2% -
Dr. Sara David Kinderarts Sint-Niklaas €342,797 €146,104 66.5% -
Dr. Bart Vergauwe, Gynaecologie Ghent €340,001 €160,327 64.0% -
Dr. Isabelle Rooms, Dermatoloog Aalter €362,506 €166,345 33.2% -
DR VASSEUR CYRIL Montigny-le-Tilleul €353,437 €144,245 44.6% -
CABINET DERMATOLOGIE BONARDEAUX Geer €355,096 €142,847 12.7% -

These companies have the same main activity as AMBAX: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €340,000 and €379,000, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 13-07-2021Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.320.083.8109820 Merelbeke-Melle, since 13-07-2021
Financial year end
31 December
Peppol
Reachable since 30-01-2025
Company details

Annual accounts 2025

€365,244▲ 57.3%
Filing
Filed on 23-07-2026, 8 days before the end of the filing period
Financials

Insights on AMBAX

AMBAX files the micro format. That format states no turnover. The gross margin rose from €92,850 in 2022 to €148,826 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about AMBAX

What is the company number of AMBAX?
The company number of AMBAX is 0771.351.522. The VAT number is the same number with BE in front: BE 0771.351.522.
Where is AMBAX based?
The registered office is at Molenstraat 73, 9820 Merelbeke-Melle.Company details
What does AMBAX do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of AMBAX?
AMBAX is a private limited company (BV).
When was AMBAX founded?
AMBAX was founded on 13-07-2021.
Is AMBAX still active?
Yes, AMBAX is an active enterprise in the KBO register.
What is the turnover of AMBAX?
The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €148,826 and 40 comparable companies (NACE 86220). It probably lies between €230,000 and €370,000.Financials
Is AMBAX profitable?
In financial year 2025, AMBAX made a profit of €76,915.
Where can I find the annual accounts of AMBAX?
AMBAX filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of AMBAX due?
AMBAX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.